SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.200
+0.250 (8.47%)
Nov 18, 2026, 4:00 PM EST - Market closed
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $288.28 million as of November 18, 2026. It is the 18,530th most valuable company in the world and the 3,257th biggest in the United States. Its market cap has increased by 73.01% in one year.
Market Cap
288.28M
Enterprise Value
189.15M
1-Year Change
73.01%
Global Rank
Country Rank
#3,257 United States
Category
ChartMarket Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has increased from $130.75M to $288.28M, an increase of 120.48%. That is a compound annual growth rate of 14.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 288.28M | 61.91% |
| Dec 31, 2025 | 178.05M | 408.46% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PepGen | 285.70M |
| Evommune | 285.52M |
| Fulcrum Therapeutics | 284.90M |
| Agenus | 283.70M |
| Precision BioSciences | 277.88M |
| Allogene Therapeutics | 276.48M |
| Lexeo Therapeutics | 274.02M |
| Turn Therapeutics | 267.51M |